Publication
Article
Supplements and Featured Publications
Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 UpdateVolume28 Issue 12
What are the current challenges to wider biosimilar use in the United States?
Author(s):
Plain Language Summary
Plain Language Summary
Click the image to open in a new window.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
